Practice Point®: Hematology
By Practice Point Communications
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Practice Point Communications
Category: Education
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 4
Reviews: 0
Episodes: 51
Description
Tune in to our hematology podcasts, where experts in the field of blood diseases unravel the complexities of hematology. Each episode covers the latest breakthroughs in the diagnosis, treatment, and management of hematologic conditions like leukemia, hemophilia, multiple myeloma and more. With in-depth discussions from leading hematologists, and insights from real-world cases, this podcast series provides healthcare professionals with the knowledge needed to navigate the world of blood disorders. Stay informed about cutting-edge research and hear inspiring stories of innovation in hematologic care.
| Episode | Date |
|---|---|
|
Episode 51 - Podcast: What I'd Do Differently Tomorrow - Part 5 of RRMM Podcasts: Practical Insights for the First Relapse
|
Jul 02, 2026 |
|
Episode 50 - Podcast: From Knowing to Doing: Overcoming Real-World Barriers - Part 4 of RRMM Podcasts: Practical Insights for the First Relapse
|
Jul 02, 2026 |
|
Episode 49 - Podcast: Bispecific Antibodies Across Targets: Practical Integration in RRMM - Part 3 of RRMM Podcasts: Practical Insights for the First Relapse
|
Jul 02, 2026 |
|
Episode 48 - Podcast: Making Sense of Immunotherapy Targets - Part 2 of RRMM Podcasts: Practical Insights for the First Relapse
|
Jul 02, 2026 |
|
Episode 47 - Podcast: First Relapse Sets the Course - Part 1 of RRMM Podcasts: Practical Insights for the First Relapse
|
Jul 02, 2026 |
|
Episode 46 - What's New Doc? End-of-the-Year Updates on CAR T-cell Therapy in Multiple Myeloma Podcast
|
Dec 17, 2025 |
|
Episode 45 - Clinical Clips® Crucial Advances in Hemophilia
|
Dec 12, 2025 |
|
Episode 44 - Hematologic Cancer Updates | Key Advances in Leukemia, MDS and MF Podcast
|
Dec 10, 2025 |
|
Episode 43 - Integrating Emerging Therapies into Clinical Practice for Pediatric ITP: Exploring Evidence, Guidelines and Best Practices
|
Jul 07, 2025 |
|
Episode 42 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 4: Patient Perspective in Hemophilia Care
|
Feb 04, 2025 |
|
Episode 41 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 3: Relevance and Impact of Novel Agents in Hemophilia Care Paradigms
|
Feb 04, 2025 |
|
Episode 40 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 2: Clinical Evidence on Novel Therapy Options in Hemophilia
|
Feb 04, 2025 |
|
Episode 39 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 1: Rationale and Potential of Gene Therapy and Rebalancing Agents in Hemophilia
|
Feb 04, 2025 |
|
Episode 38 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 5: Secondary HLH/MAS & Updates from ASH
|
Jan 20, 2025 |
|
Epsiode 37 - What’s New Doc? End of the Year Updates on CAR T-cell Therapy in Multiple Myeloma
|
Jan 20, 2025 |
|
Episode 36 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 4: Updates from ACR Convergence 2024
|
Jan 20, 2025 |
|
Episode 35 - 2024 Highlights and Hindsight in CLL End of Year Updates
|
Jan 20, 2025 |
|
Episode 34 - Clinical Clips in Acute Myeloid Leukemia: Key Updates and Breakthroughs from ASH 2024
|
Jan 20, 2025 |
|
Episode 33 - Clinical Clips in Hemophilia: Cutting-Edge Advances Presented at ASH 2024
|
Jan 20, 2025 |
|
Episode 32 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 3: Primary HLH
|
Jan 20, 2025 |
|
Episode 31 - Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal - Part 2: Diagnostic Factors and Specialty Lab Monitoring
|
Jan 20, 2025 |
|
Episode 30 - Conversations in IFN-y Driven Diseases Decoding the Gamma Signal - Part 1: Overview of Gamma Driven Diseases
|
Jan 20, 2025 |
|
Episode 29 - Relapsed/Refractory Multiple Myeloma Podcast Series: Clinical Viewpoints to Individualize Bispecific Antibody Therapy - Part 2: Sequencing Bispecific Antibodies in RRMM
|
Jan 20, 2025 |
|
Episode 28 - Relapsed/Refractory Multiple Myeloma Podcast Series: Clinical Viewpoints to Individualize Bispecific Antibody Therapy - Part 1: Rationale and Practical Considerations for Bispecific Antibodies in RRMM
|
Jan 20, 2025 |
|
Episode 27 - Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma: Patient Focused Strategies to Improve Outcomes - Part 3: Treatment of Frail Patients With NDMM and Key Emerging Trials
|
Jan 20, 2025 |
|
Episode 26 - Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma: Patient Focused Strategies to Improve Outcomes - Part 2: Treatment of Non-Frail Patients With NDMM
|
Jan 20, 2025 |
|
Episode 25 - Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma: Patient Focused Strategies to Improve Outcomes - Part 1: Risk Stratification of Patients With NDMM
|
Jan 20, 2025 |
|
Episode 24 - Podcast from EHA 2024 - Advancements in Myelofibrosis From Pathophysiology to Personalized Treatment Strategies
|
Jan 20, 2025 |
|
Episode 23 - Podcasts in Advanced Newly Diagnosed Multiple Myeloma: Updates from EHA 2024
|
Jan 20, 2025 |
|
Episode 22 - Podcasts in Pediatric ITP - Advancements in Pediatric ITP Management: Insights from EHA 2024
|
Jan 20, 2025 |
|
Episode 21 - Conversations in Relapsed/Refractory Multiple Myeloma: Strategies to Effectively Introduce, Optimize, and Sequence Bispecific Antibody Therapy - Part 3: Introducing, Optimizing, and Sequencing Bispecific Antibodies
|
Jan 20, 2025 |
|
Episode 20 - Conversations in Relapsed/Refractory Multiple Myeloma: Strategies to Effectively Introduce, Optimize, and Sequence Bispecific Antibody Therapy - Part 2: Insights into Use of Bispecific Antibodies and Recent Evidence
|
Jan 20, 2025 |
|
Episode 19 - Conversations in Relapsed/Refractory Multiple Myeloma: Strategies to Effectively Introduce, Optimize, and Sequence Bispecific Antibody Therapy - Part 1: Bispecific Antibodies in RRMM: Rationale and Efficacy
|
Jan 20, 2025 |
|
Episode 18 - Conversations in Hematology/Oncology: Incorporating Key Updates in the Treatment of Follicular Lymphoma: A Discussion Following ASH 2023 on Assimilating Practice-Changing Breakthroughs - Part 3
|
Jan 20, 2025 |
|
Episode 17 - Conversations in Hematology/Oncology: Incorporating Key Updates in the Treatment of Follicular Lymphoma: A Discussion Following ASH 2023 on Assimilating Practice-Changing Breakthroughs - Part 2
|
Jan 20, 2025 |
|
Episode 16 - Conversations in Hematology/Oncology: Incorporating Key Updates in the Treatment of Follicular Lymphoma: A Discussion Following ASH 2023 on Assimilating Practice-Changing Breakthroughs - Part 1
|
Jan 20, 2025 |
|
Episode 15 - Conference Briefs: Highlighting Myelofibrosis Clinical Data from Key Conferences - Part 3: Emerging novel agents in MF
|
Jan 20, 2025 |
|
Episode 14 - Conference Briefs: Highlighting Myelofibrosis Clinical Data from Key Conferences - Part 2: Current and emerging JAK inhibitors in MF
|
Jan 20, 2025 |
|
Episode 13 - Conference Briefs: Highlighting Myelofibrosis Clinical Data from Key Conferences - Part 1: Current unmet needs of available therapy in MF
|
Jan 20, 2025 |
|
Episode 12 - Expert Insights on ITP: How Do Emerging Treatment Strategies Have the Potential to Transform Patient Outcomes? - Part 4
|
Jan 20, 2025 |
|
Episode 11 - Expert Insights on ITP: How Do Emerging Treatment Strategies Have the Potential to Transform Patient Outcomes? - Part 3
|
Jan 20, 2025 |
|
Episode 10 - Expert Insights on ITP: How Do Emerging Treatment Strategies Have the Potential to Transform Patient Outcomes? - Part 2
|
Jan 20, 2025 |
|
Episode 9 - Expert Insights on ITP: How Do Emerging Treatment Strategies Have the Potential to Transform Patient Outcomes? - Part 1
|
Jan 20, 2025 |
|
Episode 8 - Conversations in Acute Myeloid Leukemia: Novel Therapies Targeting the Immune System for Elderly/Unfit Patients - Part 3: Novel Therapies
|
Jan 20, 2025 |
|
Episode 7 - Conversations in Acute Myeloid Leukemia: Novel Therapies Targeting the Immune System for Elderly/Unfit Patients - Part 2: Targeting the Immune System
|
Jan 20, 2025 |
|
Episode 6 - Conversations in Acute Myeloid Leukemia: Novel Therapies Targeting the Immune System for Elderly/Unfit Patients - Part 1: Current Treatment and Management
|
Jan 20, 2025 |
|
Episode 5 - Clinical Clips® Spotlighting Hot Topics in ITP
|
Jan 20, 2025 |
|
Episode 4 - Practice Changing Updates: The Evolving Treatment Landscape in Hemophilia A - Part 4
|
Jan 20, 2025 |
|
Episode 3 - Practice Changing Updates: The Evolving Treatment Landscape in Hemophilia A - Part 3
|
Jan 20, 2025 |
|
Episode 2 - Practice Changing Updates: The Evolving Treatment Landscape in Hemophilia A - Part 2
|
Jan 20, 2025 |
|
Episode 1 - Practice Changing Updates: The Evolving Treatment Landscape in Hemophilia A - Part 1
|
Jan 20, 2025 |